Join the DDA or

Ranitidine 50mg/2ml injection out of supply from June

Supply interruption due to regulatory investigation

May 11th 2020

Tagged: DM Zone news Clinical Zone news MHRA alert

By Ailsa Colquhoun

Ranitidine 50mg/2ml injection is anticipated to be unavailable from the end of May 2020 until further notice.

Ranitidine film-coated tablets, effervescent tablets and oral solution continue to remain unavailable with no date for resupply. This is due to on-going regulatory investigations into the presence of the contaminant, N-nitrosodimethylamine (NDMA).

Clinical advice on alternatives of ranitidine preparations for adults and children has been shared in the previous supply disruption alert

View the update.